Stock price when the opinion was issued
We feel that the consumer staples space is trading at attractive valuations, and for the time being, much of the reason for the decline (ozempic fears), is likely overblown. KO pays a dividend of 3.3% which is slightly above its 20-year average of 3%. Relative to its 20-year historical average valuations, its forward P/E is in line with historical averages, while its EV/EBITDA and forward price to sales are both slightly above historical averages. For an investor with a long-term time horizon, we would be quite comfortable with KO today.
Unlock Premium - Try 5i Free